-
1
-
-
34548406386
-
Thrombophilia and the obstetric patient
-
Cleary-Goldman, J., Bettes, B., Robinson, J.N., Norwitz, E. Schulkin, J. (2007) Thrombophilia and the obstetric patient. Obstetrics and Gynecology, 110, 669 674.
-
(2007)
Obstetrics and Gynecology
, vol.110
, pp. 669-674
-
-
Cleary-Goldman, J.1
Bettes, B.2
Robinson, J.N.3
Norwitz, E.4
Schulkin, J.5
-
2
-
-
34250788564
-
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin
-
20210A mutations.
-
Coppens, M., Folkeringa, N., Teune, M.J., Hamulyak, K., van der Meer, J., Prins, M.H., Buller, H.R. Middeldorp, S. (2007) Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. Journal of Thrombosis and Haemostasis, 5, 1444 1448.
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, pp. 1444-1448
-
-
Coppens, M.1
Folkeringa, N.2
Teune, M.J.3
Hamulyak, K.4
Van Der Meer, J.5
Prins, M.H.6
Buller, H.R.7
Middeldorp, S.8
-
3
-
-
0036711316
-
Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment
-
Farquharson, R.G., Quenby, S. Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics and Gynaecology, 100, 408 413.
-
(2002)
Obstetrics and Gynaecology
, vol.100
, pp. 408-413
-
-
Farquharson, R.G.1
Quenby, S.2
Greaves, M.3
-
4
-
-
9144243607
-
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
-
Girardi, G., Redecha, P. Salmon, J.E. (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Medicine, 10, 1222 1226.
-
(2004)
Nature Medicine
, vol.10
, pp. 1222-1226
-
-
Girardi, G.1
Redecha, P.2
Salmon, J.E.3
-
5
-
-
0029934389
-
Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
-
Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 1584 1589.
-
(1996)
American Journal of Obstetrics and Gynecology
, vol.174
, pp. 1584-1589
-
-
Kutteh, W.H.1
-
6
-
-
0031022366
-
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
-
Rai, R., Cohen, H., Dave, M. Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ, 314, 253 357.
-
(1997)
BMJ
, vol.314
, pp. 253-357
-
-
Rai, R.1
Cohen, H.2
Dave, M.3
Regan, L.4
-
7
-
-
33646562520
-
Antiphospholipid syndrome: An evolving story
-
Robertson, B. Greaves, M. (2006) Antiphospholipid syndrome: an evolving story. Blood Reviews, 20, 201 212.
-
(2006)
Blood Reviews
, vol.20
, pp. 201-212
-
-
Robertson, B.1
Greaves, M.2
-
8
-
-
32544441595
-
The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: A systematic review
-
Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D.O., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. Greer, I.A. (2006) The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171 196.
-
(2006)
British Journal of Haematology
, vol.132
, pp. 171-196
-
-
Robertson, L.1
Wu, O.2
Langhorne, P.3
Twaddle, S.4
Clark, P.5
Lowe, G.D.O.6
Walker, I.D.7
Greaves, M.8
Brenkel, I.9
Regan, L.10
Greer, I.A.11
-
10
-
-
23944444384
-
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. the European Prospective Cohort on Thrombophilia (EPCOT)
-
Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., Van der Meer, F.J., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459 464.
-
(2005)
Journal of Thrombosis and Haemostasis
, vol.3
, pp. 459-464
-
-
Vossen, C.Y.1
Conard, J.2
Fontcuberta, J.3
Makris, M.4
Van Der Meer, F.J.5
Pabinger, I.6
Palareti, G.7
Preston, F.E.8
Scharrer, I.9
Souto, J.C.10
Svensson, P.11
Walker, I.D.12
Rosendaal, F.R.13
-
11
-
-
33646268182
-
Screening for thrombophilia in high-risk situations: Systematic review and cost-effectiveness analysis. the Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
-
Wu, O., Robertson, L., Twaddle, S., Lowe, G.D.O., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. Greer, I. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1 110.
-
(2006)
Health Technology Assessment
, vol.10
, pp. 1-110
-
-
Wu, O.1
Robertson, L.2
Twaddle, S.3
Lowe, G.D.O.4
Clark, P.5
Greaves, M.6
Walker, I.D.7
Langhorne, P.8
Brenkel, I.9
Regan, L.10
Greer, I.11
|